What are the side effects of sofosbuvir and velpatasvir?
吉三代(sofosbuvir and velpatasvir)Applicable to patients without cirrhosis or compensated cirrhosisHCV genotypes are 1, 2, 3, hepatitis C virus (HCV) infection or decompensated cirrhosis in combination with ribavirin.
Jisandai(sofosbuvir and velpatasvir)What are the side effects?
Common side effects of Gisanda (sofosbuvir and velpatasvir) include headache (22%), fatigue (15%), decompensated cirrhosis, anemia (26%), hemoglobin< 10g/deciliter(23%), nausea(15%), headache11%), insomnia(11%), weakness(5%), increased lipase> 3 timesULN (3%), rash(2%), depression(1%), creatinine kinase increase≥10 timesULN (1%), diarrhea (10%)
, hemoglobin< 3.5g/dl(7%), etc.
The combination of sofosbuvirandvelpatasvir is taken by mouth in tablets and pills. It is usually taken once daily with or without food for 12 weeks. For children under 6 years old,Jisandai Granules should be taken with food. Take Jisandai at about the same time every day. Follow the directions on your prescription label carefully and ask your doctor to explain any parts you don't understand. Take GISANDAI as directed. Do not take more or less than prescribed by your doctor. Tell your doctor if you are pregnant, planning to become pregnant, or breastfeeding. If you become pregnant while taking GISANDAI, please contact your doctor. If you are taking GIRISTA in combination with ribavirin, you should not become pregnant during treatment with these drugs and for 6 months after treatment. Ribavirin may cause serious harm to the fetus.
There are generic drugs overseas. The officially marketed version has the same ingredients and dosage specifications as the original drug. A course of treatment costs about 3000 or so. If you want to get more high-quality information, you can contact Yaode, and Yaode will do its best to learn more about high-quality overseas drugs for you.
[ 免责声明 ] 本页面内容来自公开渠道(如FDA官网、Drugs官网、原研药厂官网等),仅供持有医疗专业资质的人员用于医学药学研究参考,不构成任何治疗建议或药品推荐。所涉药品可能未在中国大陆获批上市,不适用于中国境内销售和使用。如需治疗,请咨询正规医疗机构。本站不提供药品销售或代购服务。
.jpeg)